Milk Thistle Benefits: 7 Uses Tested, and the Liver Isn’t the Best One

Quick Answer: Milk thistle has been tested in people for 7 uses, and the liver, the reason most people buy it, has the weakest results for what it costs to find out. Two trials funded by the US National Institutes of Health gave silymarin (the milk thistle extract) at 420 or 700 mg three times a day, higher than the customary dose, and both missed their main goal: in hepatitis C only 2 people per group reached normal liver enzymes, and in fatty liver disease 15% on the high dose improved against 12% on placebo (p = 0.79). The steadiest signal is blood sugar in type 2 diabetes: a 2016 meta-analysis of 5 trials (270 patients) found HbA1c about 1 point lower, but rated the evidence low quality, and most of these trials were done in Iran. The “cancer warning” you may have seen is a precaution about estrogen, not a finding that milk thistle causes cancer.

Milk thistle (Silybum marianum) is sold mainly as a liver supplement. This page goes through each use that has been tested in randomised trials in people, says what the trial set out to show, and whether it did. For milk thistle combined with dandelion, see our dandelion root page.

The 7 uses, and what the trials found

Fatty liver: two trials, two missed goals

Fatty liver disease is the most common reason milk thistle is recommended today. Two randomised, double-blind trials took liver biopsies before and after 48 weeks:

• Navarro 2019 (US, NIH-funded). 78 people with NASH were given Legalon silymarin at 420 mg or 700 mg, or a placebo, three times a day. The goal was a 2-point improvement in the NAFLD activity score. It was reached by 4 of 27 (15%) on 700 mg, 5 of 26 (19%) on 420 mg and 3 of 25 (12%) on placebo (p = 0.79). The authors noted that fibrosis “improved most in the placebo treated group,” although not significantly, and that 63% of participants turned out not to meet the biopsy entry criteria on central review.
• Wah Kheong 2017 (Malaysia). 99 people with biopsy-proven NASH took 700 mg of silymarin or placebo three times a day. The main goal, a 30% drop in the activity score, was reached by 32.7% on silymarin and 26.0% on placebo (p = .467). On a secondary measure, more people on silymarin had less fibrosis on biopsy: 22.4% against 6.0% (p = .023). The authors concluded that silymarin “may reduce liver fibrosis but this remains to be confirmed in a larger trial.”

So the trial that hit a fibrosis result was not designed around it, and the US trial found the opposite trend. Neither trial supports the claim that milk thistle reverses fatty liver.

Hepatitis C: no difference at higher than usual doses

The SyNCH trial, funded by the NIH and published in JAMA in 2012, enrolled 154 people with chronic hepatitis C whose interferon treatment had failed. They took 420 mg or 700 mg of silymarin, or placebo, three times a day for 24 weeks. Only 2 people in each group reached the main goal of normal or halved liver enzymes (ALT): 3.8%, 4.0% and 3.8%. There was also no difference in viral load or quality of life. The authors’ conclusion: “Higher than customary doses of silymarin did not significantly reduce serum ALT levels more than placebo.”

Alcohol-related cirrhosis: the two big trials disagree

• Ferenci 1989 (Austria). 170 people with cirrhosis took 140 mg of silymarin or placebo three times a day. The 4-year survival rate was 58% with silymarin and 39% with placebo (P = 0.036), and the subgroup with alcohol-related cirrhosis did best.
• Parés 1998 (Spain). 200 people with alcohol-related cirrhosis took 150 mg three times a day or placebo for 2 years. Survival was similar in both groups, and the authors concluded that silymarin “has no effect on survival and the clinical course in alcoholics with liver cirrhosis.”

The larger, later trial did not repeat the earlier result. NCCIH describes the liver trials as a whole as “conflicting or too limited to allow conclusions to be reached.”

Blood sugar: the most consistent result

The use with the steadiest results is type 2 diabetes, where milk thistle was taken alongside usual treatment:

• Huseini 2006. 51 people with type 2 diabetes took 200 mg of silymarin or placebo three times a day for 4 months. HbA1c, fasting glucose, cholesterol and liver enzymes all fell significantly more with silymarin.
• Voroneanu 2016. A meta-analysis of 5 randomised trials and 270 patients found fasting glucose 26.86 mg/dL lower and HbA1c 1.07 points lower with silymarin. The authors added that, “being aware of the low quality of the available evidence and elevated heterogeneity of these studies, no recommendation can be made.”
• Xiao 2020. A larger meta-analysis of 16 studies with 1,358 patients with blood sugar or lipid problems found lower glucose, HbA1c and LDL cholesterol, and no effect on the liver enzymes ALT and AST.

NCCIH’s summary is that milk thistle “may help to control blood sugar in people with type 2 diabetes,” but that “most of this research was done in Middle Eastern countries, and it is unclear whether the same results would be seen in other parts of the world.” If you take diabetes medicine, a drop in blood sugar is something to discuss with your doctor before you start, not after.

Chemotherapy, breast milk and mushroom poisoning

• Chemotherapy liver damage. In a 2010 pilot trial, 50 children with acute lymphoblastic leukaemia and liver toxicity took milk thistle or placebo for 28 days. There were no significant changes in ALT, AST or bilirubin at day 28. At day 56, AST was lower in the milk thistle group (P = .05). Milk thistle did not interfere with the chemotherapy in laboratory tests.
• Breast milk supply. Milk thistle has a long history as a galactagogue, but NCCIH says “it is unclear whether milk thistle has an effect on breast milk production,” and “little is known about whether it’s safe to use milk thistle during pregnancy or while breastfeeding.”
• Death cap mushroom poisoning. In Europe, silibinin (one of the compounds in silymarin) is given intravenously as an antidote for Amanita phalloides poisoning. The National Cancer Institute describes it as “the only effective antidote” in the report it cites. This is a hospital treatment at doses of 20 to 55 mg per kg of body weight. It does not mean an oral supplement protects against poisoning.

What the “milk thistle cancer warning” is about

Several medical sites tell people with hormone-sensitive conditions to avoid milk thistle. Mayo Clinic writes: “There is also concern that milk thistle might affect estrogen levels. If you have breast cancer, uterine cancer, ovarian cancer, endometriosis or uterine fibroids, consider avoiding milk thistle.” Susan G. Komen gives the same list and says milk thistle extracts “might act like estrogen.”

That is a precaution about estrogen, not evidence that milk thistle causes cancer. The National Cancer Institute’s professional summary is more sceptical of the estrogen concern itself: “Reports that associate the flavonolignans with potential estrogenic effect (e.g., via mediation of the estrogen receptor) are sparse and currently not supported by in vitro or in vivo experimental evidence.” Elsewhere the same summary says estrogenic effects that have been reported in animals “are moderate, and the molecular mechanisms are not yet understood.” NCI also states that “the FDA has not approved the use of milk thistle as a treatment for cancer or any other medical condition.”

In practice: if you have, or have had, a hormone-sensitive cancer, or are on hormone treatment, ask your oncology team before taking it. The precaution exists because the question has not been settled in people, not because harm has been shown.

How long should you take milk thistle to “detox” your liver?

No trial has tested milk thistle as a liver detox. The trials above ran for 4 weeks (children on chemotherapy), 24 weeks (hepatitis C), 4 months (diabetes), 48 weeks (fatty liver) and 2 to 4 years (cirrhosis), and they measured liver enzymes, biopsies or survival, not “toxins.” A healthy liver does not need a supplement to clear itself. If your liver enzymes are raised, the useful step is finding out why, because the cause (alcohol, fatty liver, a medicine, a virus) decides the treatment.

What is actually in the bottle

A 2019 study tested 26 milk thistle supplements bought in the US and the Czech Republic. It found “large differences in the silymarin content” among products, “often in contrast with the information provided by the manufacturers,” and differences between batches of the same product. Mycotoxins and pesticides were detected in all of them, and many had microbial contamination. The authors suggested this may explain why clinical results have been “unsatisfactory and non-reproducible.” NCCIH repeats the same concern on its milk thistle page.

Side effects and interactions

• NCCIH: milk thistle taken by mouth “appears to be well tolerated. The most common side effects are digestive symptoms such as bloating, nausea, and gas.” In the US trials, side effects on silymarin were similar to placebo.
• It may cause allergic reactions in people allergic to related plants, such as ragweed, chrysanthemum, marigold and daisy.
• It may lower blood sugar, which matters if you take diabetes medicine.
• If you take any prescription medicine, ask your pharmacist before adding it.

Who should talk to a doctor first

• Anyone with raised liver enzymes, jaundice or diagnosed liver disease. The cause needs a diagnosis, and none of the liver trials showed milk thistle can replace treatment.
• People taking diabetes medicine, because blood sugar may fall.
• People with breast, uterine or ovarian cancer, endometriosis or fibroids, given the estrogen precaution above.
• People who are pregnant or breastfeeding.

Frequently Asked Questions

What is milk thistle good for?

The most consistent trial results are for blood sugar in type 2 diabetes: a meta-analysis of 5 trials found HbA1c about 1 point lower, though the evidence was rated low quality. For the liver, the two NIH-funded trials, in hepatitis C and fatty liver disease, found no benefit over placebo.

Does milk thistle help the liver?

The evidence is mixed at best. Trials in hepatitis C and fatty liver disease missed their main goals, and the two large cirrhosis trials disagree on survival. One fatty liver trial found less fibrosis on a secondary measure, which its authors said needs a larger trial to confirm.

Why is there a cancer warning on milk thistle?

Some sources advise people with breast, uterine or ovarian cancer, endometriosis or fibroids to avoid milk thistle because it “might affect estrogen levels.” The National Cancer Institute says reports of an estrogenic effect are “sparse and currently not supported” by experimental evidence. It is a precaution, not evidence that milk thistle causes cancer.

How long should I take milk thistle to detox my liver?

No trial has tested milk thistle for liver detox. The liver trials ran from 4 weeks to 4 years and measured enzymes, biopsies or survival. If your liver tests are abnormal, the cause matters more than any supplement.

What are the side effects of milk thistle?

Mostly digestive: bloating, nausea and gas. It can cause allergic reactions in people allergic to ragweed and related plants, and may lower blood sugar.

How much milk thistle was used in the trials?

The cirrhosis trials used 140 to 150 mg of silymarin three times a day, the diabetes trial 200 mg three times a day, and the US liver trials 420 to 700 mg three times a day, which the authors called higher than customary. Products vary widely in how much silymarin they actually contain.

The Bottom Line

Milk thistle is sold for the liver, but the liver is where its best trials came up empty: no difference in hepatitis C, missed goals in fatty liver disease, and a survival benefit in cirrhosis that a larger trial did not repeat. Its most consistent result is a modest drop in blood sugar in type 2 diabetes, from small, low-quality trials. It appears to be well tolerated, the “cancer warning” is a precaution about estrogen rather than a known harm, and what is in the bottle may not match the label. If your liver tests are abnormal, find out why before reaching for it.

Sources

1. Fried MW, et al. Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial. JAMA. 2012;308(3):274-82. PubMed 22797645. Checked 23 October 2026.
2. Navarro VJ, et al. Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: a randomized, double-blind, placebo controlled trial. PLoS One. 2019;14(9):e0221683. PubMed 31536511. Checked 23 October 2026.
3. Wah Kheong C, Nik Mustapha NR, Mahadeva S. A randomized trial of silymarin for the treatment of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol. 2017;15(12):1940-1949. PubMed 28419855. Checked 23 October 2026.
4. Ferenci P, et al. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol. 1989;9(1):105-13. PubMed 2671116. Checked 23 October 2026.
5. Parés A, et al. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. J Hepatol. 1998;28(4):615-21. PubMed 9566830. Checked 23 October 2026.
6. Huseini HF, et al. The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial. Phytother Res. 2006;20(12):1036-9. PubMed 17072885. Checked 23 October 2026.
7. Voroneanu L, et al. Silymarin in type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. J Diabetes Res. 2016;2016:5147468. PubMed 27340676. Checked 23 October 2026.
8. Xiao F, et al. The therapeutic effects of silymarin for patients with glucose/lipid metabolic dysfunction: a meta-analysis. Medicine (Baltimore). 2020;99(40):e22249. PubMed 33019400. Checked 23 October 2026.
9. Ladas EJ, et al. A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL). Cancer. 2010;116(2):506-13. PubMed 20014183. Checked 23 October 2026.
10. Fenclova M, et al. Poor chemical and microbiological quality of the commercial milk thistle-based dietary supplements may account for their reported unsatisfactory and non-reproducible clinical outcomes. Sci Rep. 2019;9(1):11118. PubMed 31366891. Checked 23 October 2026.
11. National Center for Complementary and Integrative Health. Milk Thistle (last updated February 2025). nccih.nih.gov. Checked 23 October 2026.
12. National Cancer Institute. Milk Thistle (PDQ), Health Professional Version. cancer.gov. Checked 23 October 2026.
13. Mayo Clinic. Milk thistle. mayoclinic.org. Checked 23 October 2026.
14. Susan G. Komen. Milk Thistle. komen.org. Checked 23 October 2026.